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Abstract
Background: Currently, up-regulated proteins and apoptosis in hepatitis C is a hot topic in exploring the
pathogenic mechanism of Heptitis C Virus(HCV). Some recent studies shows that prohibitin is overexpressed in cells
expressing HCV core proteins, and up-regulated prohibitin is also found in human hepatoma cell line HCC-M, lung
cancer, prostate cancer, and other cancers. Prohibitin is an important member of the membrane protein
superfamily, and it plays a role of molecular chaperones in mitochondrial protein stability. Meanwhile, it has a
permissive action on tumor growth or acts as an oncosuppressor. Based on our previously established the in vitro
HCV cell-culture system (HCVcc), here we aimed to investigate the different expression profiles of prohibitin in
Huh-7-HCV and Huh-7.5-HCV cells
Methods: The total cellular RNA of Huh-7, Huh-7.5, Huh-7-HCV and Huh-7.5-HCV cells were extracted, and then the
first-strand cDNA was reversely transcribed. The expression of prohibitin at the mRNA level was assessed by real-
time PCR with GAPDH as the control. Furthermore, the expression of prohibitin at the protein level was evaluated
by western blot with GAPDH as an internal control.
Results: Our results of real-time PCR showed that the mRNA expression level of prohibitin in Huh-7-HCV cells was
2.09 times higher than that in Huh-7 cells, while, the mRNA level of prohibitin in Huh-7.5-HCV cells was 2.25 times
higher than that in Huh-7.5 cells. The results of western blot showed that the protein expression level of prohibitin
in Huh-7-HCV cells was 2.38 times higher than that in Huh-7 cells, while the protein expression of prohibitin in
Huh-7.5-HCV cells was 2.29 times higher than that in Huh-7.5 cells.
Conclusions: The expression of prohibitin was relatively high in Huh-7-HCV and Huh-7.5-HCV cells harboring in
vitro transcribed full-length HCV RNA.
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Background
Hepatitis C virus (HCV) is a causative agent of human
hepatitis C [1]. HCV infection has become a global
health problem with a prevalence of 170 million people,
as estimated by the World Health Organization [2,3].
Most (70-80%) HCV infections persist, and about 30%
of individuals with persistent infection develop to
chronic liver disease, including liver steatosis, cirrhosis
and eventually hepatocellular carcinoma [4,5]. However,
the response rate is lower than 55% with the current
pegylated interferon and ribavirin combination therapy
in hepatitis C patients, and HCV also produces compli-
cations, such as depression and thyroid dysfunction [6].
Therefore, almost half of patients are not satisfactorily
resolved. Moreover, there are no commercial vaccines
for hepatitis C prevention, which causes a very difficult
problem.
The molecular mechanism of HCV replication, viral
persistence and pathogenesis has not yet been fully elu-
cidated. Up to now, the development of specific antiviral
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due to the lack of a convenient small animal model. The
appearance of full length HCV RNA in vitro culture sys-
tem makes it possible.
Prohibitin is a highly conserved protein, and it is
widely distributed in bacteria, plants, fungi, protozoa,
and mammals [7,8]. It is a multifunctional protein that
localizes at different intracellular sites. Prohibitin is an
important member of the membrane protein superfam-
ily, and it mainly exists in the mitochondrial inner
membrane. This protein, plays a role of molecular cha-
perones in maintaining mitochondrial protein stability.
It presents in the nucleus, involved in regulation of tran-
scription [9]. In addition, it can be found in the plasma
membrane and cytoplasm [10]. In recent years, over-
expression of prohibitin has been detected in some
tumor cells, including lung cancer, prostate cancer [11],
cervical cancer [12], bladder cancer, gastric cancer [13],
and breast cancer. Moreover, prohibitin may exert dif-
ferent functional roles, it has a permissive action on
tumor growth or acts as an oncosuppressor [14].
In the present study, we compared the expression
level of prohibitin in Huh-7 cells harboring full-length
HCV RNA (Huh-7-HCV) and control Huh-7 cells. In
addition, we evaluated its expression in Huh-7.5-HCV
cells and control Huh-7.5 cells. We investigated the pro-
hibitin expression at the mRNA level by real-time PCR
and at the protein level by western blot. Our data pro-
vided a basis for understanding the function of prohibi-
tin and the HCV pathogenesis which may lead to
alternative ways for the treatment of Hepatitis C.
Materials and methods
Cell culture and transfection
Huh-7 and Huh-7.5 cells were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) containing 10% heat-
inactivated fetal bovine serum (FBS), 0.1 mM nonessen-
tial amino acids and 1 × penicillin-streptomycin-gluta-
mine. Plasmid pFL-J6/JFH, containing a chimeric full-
length HCV genome, was kindly provided by Professor
Rice from Rockefeller University(USA), and it was tran-
scribed to HCV RNA in vitro. Subsequently, HCV RNA
was electroporately transfected into Huh-7 and Huh-7.5
cells. The in vitro HCV cell-culture system (HCVcc) was
successfully established. Huh-7-HCV and Huh-7.5-HCV
cells were maintained under the same condition as
Huh-7 and Huh-7.5 cells. Huh-7, Huh-7.5, Huh-7-HCV
and Huh-7.5-HCV cells were cultured in cell incubator
at 37°C supplemented with 5% CO2. During the cell cul-
ture, the supernatant of cell culture was collected at 24,
48 and 72 hours post-electroporation in order to deter-
mine the HCV copy numbers. In addition, transmission
electron microscopy was used to observe the morpholo-
gical characteristics of virus particles in transfected
Huh-7 and Huh-7.5 cells. Ata p p r o x i m a t e l y7 2h o u r s
post-transfection, Huh-7-HCV and Huh-7.5-HCV cells
were washed three times with 1 × phosphate-buffered
saline (PBS) and then harvested, whereas Huh-7 and
Huh-7.5 cells were collected as control.
Total RNA isolation, cDNA synthesis, RT-PCR and real-time
PCR
Total RNA was extracted from Huh-7, Huh-7.5, Huh-7-
HCV and Huh-7.5-HCV cells by TRIzol reagent (Invi-
trogen, America) according to the manufacturer’s
instructions, respectively. Briefly, every 5 × 10
6 cells
were homogenized within 1 mL TRIzol under an RNase
free environment. Chloroform was then added (200 μL
for each 1 mL TRIzol), and the sample was centrifuged
at 12,000 rpm/min at 4°C for 15 min. Subsequently, the
aqueous layer was transferred into a new tube, RNA was
precipitated with isopropanol, and the precipitate was
washed with ethanol. The RNA precipitate was then dis-
solved in 15 μL DEPC water and analyzed for quantity
and quality by a spectrophotometer(CECIL, UK). The
integrity of total RNA was examined by electrophoresis
on a 0.8% agarose gel, and the quantity was determined
based on the absorbance at 260 nm (A260). Finally, the
RNA purity was analyzed by the ratio of OD 260/280,
and the sample with a value between 1.7 and 2.0 was
selected (Table 1).
A two-step reverse transcription PCR was performed.
The first-strand cDNA was synthesized from 1 μgo f
total RNA with AMV Reverse Transcriptase(TAKARA,
Japan). To create the real-time PCR standard, prohibitin
and Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) were amplified by the specific primers. PCR
was performed on MJ Research PTC-200 (MJ Research,
America) in a 25 μL reaction system containing the fol-
lowing components: 12.5 μL 2 × Taq PCR Master Mix
(Qiagen, Germany), 1 μL cDNA template, 1.5 μLf o r -
ward primer (10 μM), 1.5 μL reverse primer (10 μM)
and 8.5 μL ddH2O .T a b l e2s h o w sa l lt h ep r i m e r
sequences. Briefly, following a denaturation at 95°C for
5 min, PCR was carried out with 35 cycles at a melting
temperature of 95°C for 30 sec, an annealing tempera-
ture of 60°C for 30 sec, and an extension temperature of
72°C for 1 min. Finally, an elongation step at 72°C for
30 min was preformed. The amplicons were examined
on 1% agarose gel by electrophoresis.
Table 1 Summary of RNA quantification
Cells Absorbance(260.0 nm) OD260/OD280 Conc (μg/mL)
Huh7 2.980 1.992 870.4
Huh7.5 2.940 1.976 906.0
Huh7-HCV 2.940 1.912 816.0
Huh7.5-HCV 2.990 1.972 834.0
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Page 2 of 6In order to examine the mRNA expression of prohi-
bitin, the expression of prohibitin and GAPDH genes
was quantified by real-time PCR, and GAPDH served
as an internal control. The length of the amplified
PCR products ranged from 50 to 150 bp as recom-
mended by Applied Biosystems. A total of 20 ng
cDNA was used as template in the reaction. All real-
time PCR assays were performed in triplicate with Bio-
Rad iQ5 Multicolor Real-time PCR Detection System
(America)according to the manufacture’sp r o t o c o l .
Briefly, following a denaturation at 95°C for 5 sec, real-
time PCR was carried out with 50 cycles at a melting
temperature of 95°C for 30 sec, an annealing tempera-
ture of 60°C for 30 sec, and an extension temperature
of 72°C for 10 sec. Data analysis was performed with
the Sequence Detector System software. The relative
quantification was calculated by the
ΔΔCt method with
GAPDH as the housekeeping gene and the non-trans-
fected cells as the baseline, and the results were
expressed as fold-change.
Protein extraction, SDS-PAGE and western blotting
To compare protein expression between the trans-
fected and non-transfected cells, the total proteins
were prepared by RIPA cell lysate. Proteins of interest
were separated by SDS-polyacrylamide gel electro-
phoresis (PAGE) with a 10% polyacrylamide gel, and
the protein concentrationl o a d e do nt h eS D S - P A G E
was always at 1 mg/mL. Proteins were transferred to
nitrocellulose membranes and then detected by wes-
tern blotting under the recommended conditions.
Rabbit anti-human IgG (Santa, America) was used as
the primary antibody, goat anti-rabbit IgG conjugated
with horseradish peroxidase (HRP) was used as the
secondary antibody, and GAPDH was used as control.
The antigen-antibody complex was detected by an
enhanced chemiluminescence (ECL) kit following the
manufacturer’s protocol. The chemiluminescent signal
of each band was analyzed by gel image analysis sys-
tem. The expression levels of prohibitin and GAPDH
in Huh-7-HCV and Huh-7.5-HCV cells were com-
pared with those in Huh-7 and Huh-7.5 cells
separately.
Results
Detection of HCV at the RNA level in infected cellular
supernatant and transmission electron microscopy
observation
We detected HCV RNA in the supernatant of infected
Huh-7 and Huh-7.5 cells. It reached a peak value at 48
hours post-transfection (6.4 × 10
6 copies), and the HCV
RNA maintained at the same level in the supernatant until
72 hours post-transfection. The electron microscopy
demonstrated that the cytoplasm of Huh-7-HCV and
Huh-7.5-HCV cells contained a large number of spherical
structures, which might be the nucleocapsid-like particles.
Some characteristics of Flaviviridae virus infection
appeared in the internal cellular structure, the rough endo-
plasmic reticulum increased, the endoplasmic network
management dilated, vacuolar structures appeared in the
cytoplasm, and a large number of HCV nucleocapsid-like
particles of inclusion body presented in Huh-7-HCV and
Huh-7.5-HCV cells. We did not find any form of virus-
like particles in the control cells. Moreover, we did not
observe the hyperplasia, vacuolar membrane structure and
formation of inclusion bodies in the control cells.
Prohibitin expression at the mRNA level was up-regulated
in Huh-7-HCV and Huh-7.5-HCV cells by real-time PCR
The extracted total cellular RNA was examined by elec-
trophoresis on a 0.8% non-denaturing agarose gel. Fig-
ure 1 shows that a 835-bp fragment of the full coding
sequence of prohibitin was successfully amplified by RT-
Table 2 Primers used for RT-PCR and real-time PCR
Name Forward primer (5’-3’) Reverse primer (5’-3’)
Prohibitin
(RT-PCR, 835 bp)
GAAGATCTATGGCTGCCAAAGTGTTTGAG CGGGATCCTCACTGGGGCAGCTGGA
Prohibitin
(real-time PCR, 129 bp)
AAACAGGTGGCTCAGCAGGAA CAGTGAGTTGGCAATCAGCTCAG
GAPDH
(real-time PCR, 138 bp)
GCACCGTCAAGGCTGAGAAC TGGTGAAGACGCCAGTGGA
Figure 1 Prohibitin was amplified by RT-PCR.N o t e :M :D N A
Marker || (Qiagen, Germany); P: Prohibitin.
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Page 3 of 6PCR without unspecific amplification. Figure 2 shows
the melt curve of prohibitin expression. A Single peak
was detected in all amplifications, suggesting that the
primers were properly designed and the prohibitin was
specifically amplified. Figure 3 shows the amplification
curve of prohibitin. Figure 4 shows that prohibitin
expression in Huh-7-HCV cells was 2.09 times higher
than that in Huh-7 cells, and prohibitin expression in
Huh-7.5-HCV cells was 2.25 times higher than that in
Huh-7.5 cells. The expression level of prohibitin was sig-
nificantly higher expressed in Huh-7 and Huh-7.5 cells
transfected with full-length HCV RNA.
Prohibitin expression at the protein level was up-
regulated in Huh-7-HCV and Huh-7.5-HCV cells by
western blot analysis
Using western blotting, we compared the chemilumines-
cent signals of prohibitin and GAPDH in Huh-7-HCV and
Huh-7.5-HCV cells with those in Huh-7 and Huh-7.5
cells, and the ratio between prohibitin and GAPDH
reflected changes of prohibitin. The results showed that
the ratio of prohibitin/GAPDH was 0.721 ± 0.025 and 0.30
± 0.012 in Huh-7-HCV cells and Huh-7 cells, respectively,
demonstrating that the prohibitin expression in Huh-7-
HCV cells was significantly higher than that in Huh-7
cells. Furthermore, the ratio of prohibitin/GAPDH was
0.78 ± 0.070 in Huh-7.5-HCV cells, which was significantly
higher than that in Huh-7.5 cells (0.34 ± 0.025) (Figure 5).
The statistical analysis revealed that the difference between
these two groups was statistically significant (P < 0.05).
Therefore, we confirmed that the expression level of pro-
hibitin was increased in Huh-7-HCV and Huh-7.5-HCV
cells. These findings demonstrated that the over-expres-
sion of prohibitin was related to HCV infection.
Discussion
Currently, much attention has been paid to the relation-
ship between the up-regulated proteins after HCV
AB
Figure 2 Melt curve of prohibitin expression detected by real-
time PCR. A. Melt curve of prohibitin in Huh-7 and Huh-7-HCV
cells. B. Melt curve of prohibitin in Huh-7.5 and Huh-7.5-HCV cells.
AB
Figure 3 The amplification curve of prohibitin expression
detected by real-time PCR. A. The amplification curve of
prohibitin in Huh-7 and Huh-7-HCV cells. B. The amplification curve
of prohibitin in Huh-7.5 and Huh-7.5-HCV cells.
Figure 4 Prohibitin mRNA relative expression rate in either
Huh-7 and Huh-7-HCV cells, or Huh-7.5 and Huh-7.5-HCV cells.
A
Huh-7      Huh-7-HCV    Huh-7.5    Huh-7.5-HCV
prohibitin
GAPDH
B
Figure 5 The prohibitin expression at the protein level by
western blot. A. Prohibitin expression in Huh-7, Huh-7-HCV, Huh-
7.5 and Huh-7.5-HCV cells. B. Relative prohibitin expression
normalized to GAPDH.
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Page 4 of 6infection and the pathology of liver injury. It is known
that HCV creates the living environment for its repro-
duction, and it survives in the host cells by affecting the
host cell apoptosis. Pathological changes in the liver tis-
sue of hepatitis C patients include the lobular necrosis,
the portal area like edge of eosinophilic necrosis, acido-
philic corpuscle or Councilman bodies. Furthermore,
apoptosis plays an important role in the pathogenesis of
hepatitis C.
We hypothesized that the up-regulated proteins by
HCV infection had a direct connection with the patho-
logical liver injury. The new discovery of up-regulated
proteins and elucidation of pathogenic mechanisms
could provide some important insights into the treat-
ment of hepatitis C. Tsutsumi et al. (2009) reported that
the prohibitin expression is up-regulated not only in the
HCV cells expressing core-protein, but also in the whole
genome replication cells as well as the liver of core-gene
transgenic mice [15]. Their results suggest that high
expression of prohibitin is significantly related to the
cellular mitochondrial metabolism.
M c C l u n ge ta l .f i r s tc l o n e d mammalian prohibitin
gene in 1989. The prohibitin gene is located in chromo-
some 17q21, encoding a protein with a molecular weight
of 32 kD [16]. It is known that prohibitin protein func-
tions as molecular chaperons and is involved in mito-
chondrial protein stability [17]. In addition, prohibitin
protein may contribute to the regulation of cell cycle
[18], regulation of cell signal transduction, inhibition of
cell proliferation [19], induction of apoptosis [20], anti-
aging, maintenance of cell homeostasis and many cellu-
lar activities of life. However, its functional roles have
not been well-defined and its specific mechanisms are
unknown.
Jang et al. found that the expression of prohibitin is
down-regulated in gastric cancer [21]. Gamble et al.
found that the expression of prohibitin is down-regu-
lated more than 50% in androgen-mediated prostate
cancer [22]. In recent years, with the advance of experi-
mental techniques, more and more studies show that
the expression of prohibitin is up-regulated in tumor tis-
sues and cells. For example, Seow et al. reported that
the expression of prohibitin is up-regulated when
detecting differentially expressed proteins in human
hepatoma cell line HCC-M using two-dimensional elec-
trophoresis [23].
In our study, we found that prohibitin was up-regu-
lated in human hepatoma cells transfected with full-
length HCV RNA compared with the control cells. Real-
time PCR revealed that the prohibitin expression at the
mRNA level in Huh-7-HCV cells was 2.09 times higher
than that in Huh-7 control cells; while the prohibitin
expression at the mRNA level in Huh-7.5-HCV cells
was 2.25 times higher than that in Huh-7.5 control cells.
Western blot analysis demons t r a t e dt h a tt h ep r o h i b i t i n
expression at the protein level in Huh-7-HCV cells was
2.38 times higher than that in Huh-7 control cells; while
the prohibitin expression at the protein level in Huh-
7.5-HCV cells was 2.29 times higher than that in Huh-
7.5 control cells. Prohibitin was over-expressed both in
Huh-7-HCV and Huh-7.5-HCV cells, which confirmed
the universility of prohibitin up-regulating. Overexpres-
sion of prohibitin may have a close relationship with
HCV RNA transcription, its down-regulation might
decrease the replication of HCV RNA. In future, we will
investigate the biological role of prohibitin and reveal
the relationship between prohibitin and apoptosis.
Those studies will provide a better understanding on
the pathogenic mechanism of HCV and develop better
approaches for the treatment of Hepatitis C.
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